药物信息为CAPOZIDE 25/15CAPOZIDE 25/25CAPOZIDE 50/15CAPOZIDE 50/25 (captopril and hydrochlorothiazide tablets, USP) (Par Pharmaceutical Companies, Inc.): USE IN PREGNANCY
- USE IN PREGNANCY
- DESCRIPTION
- INDICATIONS AND USAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Diseases/Conditions Related to CAPOZIDE 25/15CAPOZIDE 25/25CAPOZIDE 50/15CAPOZIDE 50/25 (captopril and hydrochlorothiazide tablets, USP) (Par Pharmaceutical Companies, Inc.)
- 外部链接相关的CAPOZIDE 25/15CAPOZIDE 25/25CAPOZIDE 50/15CAPOZIDE 50/25 (captopril and hydrochlorothiazide tablets, USP) (Par Pharmaceutical Companies, Inc.)
When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, CAPOZIDE® should be discontinued as soon as possible. See WARNINGS: Captopril: Fetal/Neonatal Morbidity and Mortality.
- Drug Information Provided by National Library of Medicine (NLM).
这个站点被设计主要作为提示系统供合格的医师和其他医疗专家使用。 通过使用这个站点您了解并且接受DiagnosisPro.com不会使用作为一个诊断决策系统，并且不能使用做一个临床诊断或替换或者否决一位被准许的医疗保健专家的评断或临床诊断 (充分的使用条款). 我们遵循健康网络基金会的 医学和健康网站的行为准则. 点击这里核实
© 2012 MedTech USA, Inc. (最后更新在05/25/12)
